英文字典中文字典


英文字典中文字典51ZiDian.com



中文字典辞典   英文字典 a   b   c   d   e   f   g   h   i   j   k   l   m   n   o   p   q   r   s   t   u   v   w   x   y   z       







请输入英文单字，中文词皆可：


请选择你想看的字典辞典：
单词字典翻译
074491查看　074491　在百度字典中的解释百度英翻中〔查看〕
074491查看　074491　在Google字典中的解释Google英翻中〔查看〕
074491查看　074491　在Yahoo字典中的解释Yahoo英翻中〔查看〕

安装中文字典英文字典查询工具!


中文字典英文字典工具:
选择颜色:
输入中英文单字

































































英文字典中文字典相关资料:


  • XYWAV for Idiopathic Hypersomnia | XYWAV® IH
    XYWAV ® (calcium, magnesium, potassium, and sodium oxybates) oral solution, 0 5 g mL total salts (equivalent to 0 413 g mL of oxybate) is a prescription medicine used to treat: the following symptoms in people 7 years of age or older with narcolepsy: sudden onset of weak or paralyzed muscles (cataplexy) excessive daytime sleepiness (EDS)
  • Xywav: Uses, Dosage, Side Effects, Warnings - Drugs. com
    Xywav is a medicine used to treat cataplexy (sudden loss of muscle strength) or to reduce excessive daytime sleepiness (EDS) caused by narcolepsy Xywav is also used in adults to treat idiopathic hypersomnia (IH) , which is an uncommon, chronic sleep disorder that causes daytime sleepiness even after a good night's sleep
  • Xywav for idiopathic hypersomnia: Side effects, cost, and more
    Xywav is also approved to treat excessive daytime sleepiness and cataplexy (sudden muscle weakness) related to narcolepsy Side effects of Xywav when used to treat these narcolepsy-related
  • How Xywav Works, And Other Questions Answered - GoodRx
    In August 2021, the FDA approved Xywav as a treatment option for IH In fact, it’s the only medication that’s FDA-approved for this condition Xywav was originally FDA-approved in 2002 to treat excessive daytime sleepiness (EDS) and cataplexy Journal of Clinical Sleep Medicine Schneider, L D , et al (2023)
  • Xywav Cuts Symptoms of Idiopathic Hypersomnia | Sleep Review
    Xywav significantly reduced the excessive daytime sleepiness that is a typical hallmark of the sleep disorder idiopathic hypersomnia ESS score of 16 1 (3 6), indicating substantial excessive daytime sleepiness During the Xywav open the best cutoff to differentiate individuals with untreated idiopathic hypersomnia from a control
  • XYWAV Efficacy in Idiopathic Hypersomnia Treatment | XYWAV HCP
    XYWAV ® (calcium, magnesium, potassium, and sodium oxybates) oral solution, 0 5 g mL total salts (equivalent to 0 413 g mL of oxybate) is indicated for the treatment of cataplexy or excessive daytime sleepiness (EDS) in patients 7 years of age and older with narcolepsy, and for the treatment of idiopathic hypersomnia (IH) in adults
  • Xywav: A New Hope for Patients with Narcolepsy and Excessive Daytime . . .
    Xywav is designed for long-term use in managing narcolepsy and excessive daytime sleepiness Understanding the potential for dependence and strategies for safe discontinuation is crucial for patients and healthcare providers Potential for Dependence Xywav, like other CNS depressants, carries a risk of dependence
  • XYWAV for Narcolepsy Idiopathic Hypersomnia | XYWAV®
    XYWAV oral solution, 0 5 g mL total salts (equivalent to 0 413 g mL of oxybate) is the only FDA‑approved treatment for cataplexy and or excessive daytime sleepiness in narcolepsy and for idiopathic hypersomnia (IH) in adults
  • FDA approves Xywav to treat narcolepsy | Sleep medicine | AASM
    Jazz Pharmaceuticals announced July 22, 2020, that the U S Food and Drug Administration has approved the Xywav oral solution for the treatment of cataplexy or excessive daytime sleepiness in patients with narcolepsy who are 7 years of age and older Multiple Xywav dosing options are available for adult and pediatric patients About Xywav





中文字典-英文字典  2005-2009